---
title: 'Co-observation of germline pathogenic variants in breast cancer predisposition
  genes: Results from analysis of the BRIDGES sequencing dataset'
date: '2024-08-03'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39096911/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240804182128&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Co-observation of a gene variant with a pathogenic variant in another
  gene that explains the disease presentation has been designated as evidence against
  pathogenicity for commonly used variant classification guidelines. Multiple variant
  curation expert panels have specified, from consensus opinion, that this evidence
  type is not applicable for the classification of breast cancer predisposition gene
  variants. Statistical analysis of sequence data for 55,815 individuals diagnosed
  with ...
disable_comments: true
---
Co-observation of a gene variant with a pathogenic variant in another gene that explains the disease presentation has been designated as evidence against pathogenicity for commonly used variant classification guidelines. Multiple variant curation expert panels have specified, from consensus opinion, that this evidence type is not applicable for the classification of breast cancer predisposition gene variants. Statistical analysis of sequence data for 55,815 individuals diagnosed with ...